As such, our results documenting beneficial effects of WNK3-SPAK inhibition in the MCAO model of cerebral edema suggest this complex could be as a novel therapeutic target for a medical problem of high morbidity and mortality commonly associated with stroke, tumor, trauma, infection, and other intracranial pathologies61. This evidence concerns the gene STK39 and edema.